Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Bristol-Myers Squibb launches Vagistat-1 as OTC in the U.S.

May 13, 1997

Penederm receives approval for butenafine in Canada

May 12, 1997

Wakunaga prepares novel antibacterial agents

May 9, 1997

Antiparasitic depsipeptides from Meiji Seika

May 9, 1997

AMBI to submit IND for nisin

May 8, 1997

FDA requests additional data to support Gilead's NDA for HSV treatment

May 8, 1997

MedImmune reports further clinical results for MEDI-493

May 8, 1997

Pharmacia & Upjohn prepares new antibacterial agents

May 8, 1997

N-Oxide oxazolidinones from Pharmacia & Upjohn

May 7, 1997

Salix to commence clinical trials with Normix

May 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...